Logo image of BV

BRIGHTVIEW HOLDINGS INC (BV) Stock Fundamental Analysis

NYSE:BV - New York Stock Exchange, Inc. - US10948C1071 - Common Stock - Currency: USD

16.14  -0.19 (-1.16%)

After market: 16.14 0 (0%)

Fundamental Rating

4

BV gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 83 industry peers in the Commercial Services & Supplies industry. While BV seems to be doing ok healthwise, there are quite some concerns on its profitability. BV has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year BV was profitable.
BV had a positive operating cash flow in the past year.
In multiple years BV reported negative net income over the last 5 years.
In the past 5 years BV always reported a positive cash flow from operatings.
BV Yearly Net Income VS EBIT VS OCF VS FCFBV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M 200M

1.2 Ratios

With a Return On Assets value of -0.05%, BV perfoms like the industry average, outperforming 43.37% of the companies in the same industry.
BV's Return On Equity of -0.10% is in line compared to the rest of the industry. BV outperforms 45.78% of its industry peers.
BV has a Return On Invested Capital (2.95%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for BV is significantly below the industry average of 11.67%.
The last Return On Invested Capital (2.95%) for BV is above the 3 year average (2.40%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.05%
ROE -0.1%
ROIC 2.95%
ROA(3y)0.26%
ROA(5y)0.17%
ROE(3y)0.6%
ROE(5y)0.4%
ROIC(3y)2.4%
ROIC(5y)2.06%
BV Yearly ROA, ROE, ROICBV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 -4 -6

1.3 Margins

BV's Profit Margin has declined in the last couple of years.
BV has a Operating Margin of 4.50%. This is comparable to the rest of the industry: BV outperforms 45.78% of its industry peers.
BV's Operating Margin has declined in the last couple of years.
BV has a Gross Margin of 23.23%. This is in the lower half of the industry: BV underperforms 67.47% of its industry peers.
BV's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.5%
PM (TTM) N/A
GM 23.23%
OM growth 3Y4.93%
OM growth 5Y-5.36%
PM growth 3Y-27.02%
PM growth 5Y-17.52%
GM growth 3Y-2.9%
GM growth 5Y-2.54%
BV Yearly Profit, Operating, Gross MarginsBV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BV is destroying value.
Compared to 1 year ago, BV has more shares outstanding
The number of shares outstanding for BV has been reduced compared to 5 years ago.
The debt/assets ratio for BV has been reduced compared to a year ago.
BV Yearly Shares OutstandingBV Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BV Yearly Total Debt VS Total AssetsBV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

BV has an Altman-Z score of 1.59. This is a bad value and indicates that BV is not financially healthy and even has some risk of bankruptcy.
BV's Altman-Z score of 1.59 is on the low side compared to the rest of the industry. BV is outperformed by 66.27% of its industry peers.
The Debt to FCF ratio of BV is 8.01, which is on the high side as it means it would take BV, 8.01 years of fcf income to pay off all of its debts.
BV's Debt to FCF ratio of 8.01 is fine compared to the rest of the industry. BV outperforms 62.65% of its industry peers.
A Debt/Equity ratio of 0.45 indicates that BV is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.45, BV perfoms like the industry average, outperforming 55.42% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 8.01
Altman-Z 1.59
ROIC/WACC0.37
WACC8.09%
BV Yearly LT Debt VS Equity VS FCFBV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.42 indicates that BV should not have too much problems paying its short term obligations.
BV's Current ratio of 1.42 is on the low side compared to the rest of the industry. BV is outperformed by 60.24% of its industry peers.
A Quick Ratio of 1.42 indicates that BV should not have too much problems paying its short term obligations.
BV has a Quick ratio (1.42) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.42
BV Yearly Current Assets VS Current LiabilitesBV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.26% over the past year.
The Earnings Per Share has been decreasing by -8.19% on average over the past years.
BV shows a decrease in Revenue. In the last year, the revenue decreased by -2.85%.
Measured over the past years, BV shows a small growth in Revenue. The Revenue has been growing by 2.85% on average per year.
EPS 1Y (TTM)5.26%
EPS 3Y-14.5%
EPS 5Y-8.19%
EPS Q2Q%27.27%
Revenue 1Y (TTM)-2.85%
Revenue growth 3Y2.71%
Revenue growth 5Y2.85%
Sales Q2Q%-1.53%

3.2 Future

The Earnings Per Share is expected to grow by 14.57% on average over the next years. This is quite good.
Based on estimates for the next years, BV will show a small growth in Revenue. The Revenue will grow by 2.61% on average per year.
EPS Next Y15.66%
EPS Next 2Y14.89%
EPS Next 3Y14.57%
EPS Next 5YN/A
Revenue Next Year0.77%
Revenue Next 2Y1.88%
Revenue Next 3Y2.61%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BV Yearly Revenue VS EstimatesBV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
BV Yearly EPS VS EstimatesBV Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 20.18, which indicates a rather expensive current valuation of BV.
66.27% of the companies in the same industry are more expensive than BV, based on the Price/Earnings ratio.
BV's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.55.
With a Price/Forward Earnings ratio of 16.30, BV is valued correctly.
BV's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BV is cheaper than 71.08% of the companies in the same industry.
BV is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.40, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.18
Fwd PE 16.3
BV Price Earnings VS Forward Price EarningsBV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

77.11% of the companies in the same industry are more expensive than BV, based on the Enterprise Value to EBITDA ratio.
72.29% of the companies in the same industry are more expensive than BV, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.41
EV/EBITDA 8.08
BV Per share dataBV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

BV's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as BV's earnings are expected to grow with 14.57% in the coming years.
PEG (NY)1.29
PEG (5Y)N/A
EPS Next 2Y14.89%
EPS Next 3Y14.57%

0

5. Dividend

5.1 Amount

BV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BRIGHTVIEW HOLDINGS INC

NYSE:BV (6/11/2025, 8:04:01 PM)

After market: 16.14 0 (0%)

16.14

-0.19 (-1.16%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)07-29 2025-07-29/amc
Inst Owners67.39%
Inst Owner Change-1.08%
Ins Owners2.94%
Ins Owner Change0.44%
Market Cap1.54B
Analysts81.11
Price Target20.08 (24.41%)
Short Float %9.08%
Short Ratio8.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.19
Dividend Growth(5Y)N/A
DP-1988.89%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.9%
Min EPS beat(2)1.9%
Max EPS beat(2)21.9%
EPS beat(4)2
Avg EPS beat(4)4.4%
Min EPS beat(4)-4.54%
Max EPS beat(4)21.9%
EPS beat(8)4
Avg EPS beat(8)-2%
EPS beat(12)6
Avg EPS beat(12)7.72%
EPS beat(16)7
Avg EPS beat(16)3.83%
Revenue beat(2)0
Avg Revenue beat(2)-2.62%
Min Revenue beat(2)-4.84%
Max Revenue beat(2)-0.41%
Revenue beat(4)0
Avg Revenue beat(4)-2.51%
Min Revenue beat(4)-4.84%
Max Revenue beat(4)-0.41%
Revenue beat(8)0
Avg Revenue beat(8)-3.49%
Revenue beat(12)1
Avg Revenue beat(12)-2.5%
Revenue beat(16)3
Avg Revenue beat(16)-1.65%
PT rev (1m)2.21%
PT rev (3m)3.55%
EPS NQ rev (1m)-2.83%
EPS NQ rev (3m)-3.62%
EPS NY rev (1m)1.09%
EPS NY rev (3m)0.41%
Revenue NQ rev (1m)-0.68%
Revenue NQ rev (3m)-0.64%
Revenue NY rev (1m)0.28%
Revenue NY rev (3m)0.21%
Valuation
Industry RankSector Rank
PE 20.18
Fwd PE 16.3
P/S 0.56
P/FCF 15.41
P/OCF 6.21
P/B 0.87
P/tB N/A
EV/EBITDA 8.08
EPS(TTM)0.8
EY4.96%
EPS(NY)0.99
Fwd EY6.13%
FCF(TTM)1.05
FCFY6.49%
OCF(TTM)2.6
OCFY16.11%
SpS28.64
BVpS18.56
TBVpS-3.44
PEG (NY)1.29
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.05%
ROE -0.1%
ROCE 4.36%
ROIC 2.95%
ROICexc 3.11%
ROICexgc 14.3%
OM 4.5%
PM (TTM) N/A
GM 23.23%
FCFM 3.66%
ROA(3y)0.26%
ROA(5y)0.17%
ROE(3y)0.6%
ROE(5y)0.4%
ROIC(3y)2.4%
ROIC(5y)2.06%
ROICexc(3y)2.47%
ROICexc(5y)2.14%
ROICexgc(3y)10.98%
ROICexgc(5y)10.41%
ROCE(3y)3.54%
ROCE(5y)3.05%
ROICexcg growth 3Y-0.5%
ROICexcg growth 5Y-6.24%
ROICexc growth 3Y6.57%
ROICexc growth 5Y-3.78%
OM growth 3Y4.93%
OM growth 5Y-5.36%
PM growth 3Y-27.02%
PM growth 5Y-17.52%
GM growth 3Y-2.9%
GM growth 5Y-2.54%
F-Score4
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 8.01
Debt/EBITDA 2.91
Cap/Depr 97.88%
Cap/Sales 5.42%
Interest Coverage 1.98
Cash Conversion 90.41%
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 1.42
Altman-Z 1.59
F-Score4
WACC8.09%
ROIC/WACC0.37
Cap/Depr(3y)57.78%
Cap/Depr(5y)51.34%
Cap/Sales(3y)3.08%
Cap/Sales(5y)2.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.26%
EPS 3Y-14.5%
EPS 5Y-8.19%
EPS Q2Q%27.27%
EPS Next Y15.66%
EPS Next 2Y14.89%
EPS Next 3Y14.57%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.85%
Revenue growth 3Y2.71%
Revenue growth 5Y2.85%
Sales Q2Q%-1.53%
Revenue Next Year0.77%
Revenue Next 2Y1.88%
Revenue Next 3Y2.61%
Revenue Next 5YN/A
EBIT growth 1Y4.42%
EBIT growth 3Y7.78%
EBIT growth 5Y-2.67%
EBIT Next Year78.32%
EBIT Next 3Y26.64%
EBIT Next 5YN/A
FCF growth 1Y195.27%
FCF growth 3Y13.41%
FCF growth 5Y9.77%
OCF growth 1Y107.19%
OCF growth 3Y11.48%
OCF growth 5Y3.91%